• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EUCLID VISION CORPORATION EUCLID MAX ORTHOKERATOLOGY CONTACT LENS; LENS, CONTACT (RIGID GAS PERMEABLE), EXTENDED WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EUCLID VISION CORPORATION EUCLID MAX ORTHOKERATOLOGY CONTACT LENS; LENS, CONTACT (RIGID GAS PERMEABLE), EXTENDED WEAR Back to Search Results
Lot Number F2101470 , F2101672
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Insufficient Information (4580)
Event Date 10/01/2022
Event Type  Injury  
Manufacturer Narrative
Manufacturer intiating investigation since this was the first time the manufacturer was made aware of this situation and the device has not been returned for inspection.A follow-up report will be filled with the investigation details.
 
Event Description
On 01/03/2023 euclid vision corporation received the medwatch report no.(mw5113998) from fda about a patient allegation pertaining to euclid lenses.This was the first time that the manufacturer was made aware of the situation.An investigation has been opened complaint no.(b)(4).Has been assigned.
 
Manufacturer Narrative
Manufacturer initiating investigation since this was the first time the manufacturer was made aware of this situation and the device has not been returned for inspection.This follow up report (#01) includes a status update of the investigation.The prescriber physician has been contacted several times about this report and confirmed a follow up appointment with the patient scheduled for (b)(6) 2023.A follow up report will be filled by the manufacturer to include additional details about the findings.
 
Event Description
On 01/03/2023, euclid vision corporation received the medwatch report no.(mw5113998) from fda about a patient allegation pertaining to euclid lenses.This was the first time that the manufacturer was made aware of the situation.An investigation has been opened complaint no.(b)(4) has been assigned.This follow up report (#1) includes a status update of the investigation.
 
Manufacturer Narrative
Manufacturer initiating investigation since this was the first time the manufacturer was made aware of this situation and the device has not been returned for inspection.This follow up report (#3 final) includes the final update of the investigation.Lenses were not received for testing.In (b)(6) 2022, during final appointment with the physician, the doctor found that patient vision was back to normal, 20/20 correction in both eyes and patient returned to wearing glasses.The physician did not consider that the device caused the situation.03/10/2023, this report is now closed.
 
Event Description
On 01/03/2023, euclid vision corporation received the medwatch report no.(mw5113998) from fda about a patient allegation pertaining to euclid lenses.This was the first time that the manufacturer was made aware of the situation.An investigation has been opened complaint no.(b)(4) has been assigned.This follow up report (#3) includes a status update of the investigation.In (b)(6) 2022, the patient went in for a routine annual exam.The patient was still wearing lenses at night and was doing well.The physician did not see any problems.Patient was advised to return for a follow-up in 6 months.On (b)(6) 2022, patient went in for a follow-up exam.The patient presented an infection determined to be caused by an unknown irritation.The patient was advised to stop wearing his lenses and was treated with antibiotics, standard treatment for eye infection.The physician did not believe that the lens was the cause of the infection.On (b)(6) 2023, patient went in for a follow-up with physician.Vision was back to normal, with 20/20 correction in both eyes, which triggered patient to return to wearing glasses.
 
Event Description
On 01/03/2023, euclid vision corporation received the medwatch report no.(mw5113998) from fda about a patient allegation pertaining to euclid lenses.This was the first time that the manufacturer was made aware of the situation.An investigation has been opened complaint no.(b)(4) has been assigned.This follow up report (#2) includes a status update of the investigation.
 
Manufacturer Narrative
Manufacturer initiating investigation since this was the first time the manufacturer was made aware of this situation and the device has not been returned for inspection.This follow up report (#2) includes a status update of the investigation.As of date 03/03/2023, the prescriber physician has been contacted  several times about his assesment of the situation but his feedback has not been presented to manufacturer. a follow up report will be filled by the manufacturer to include  additional details about this situation, if any.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUCLID MAX ORTHOKERATOLOGY CONTACT LENS
Type of Device
LENS, CONTACT (RIGID GAS PERMEABLE), EXTENDED WEAR
Manufacturer (Section D)
EUCLID VISION CORPORATION
45472 holiday drive
suite7
sterling VA 20166
Manufacturer (Section G)
EUCLID VISION CORPORATION
45472 holiday drive
suite7
sterling 20166
Manufacturer Contact
sandra freitez
45472 holiday drive
suite7
sterling 20166
7034717145
MDR Report Key16135313
MDR Text Key307105815
Report Number3014175039-2023-00001
Device Sequence Number1
Product Code MWL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 03/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Lot NumberF2101470 , F2101672
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/03/2023
Initial Date FDA Received01/10/2023
Supplement Dates Manufacturer Received01/03/2023
01/03/2023
01/03/2023
Supplement Dates FDA Received02/01/2023
03/03/2023
03/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/23/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-